tingling; Paresthesia; fatigue; lightheadedness; weakness; itching; shooting pains; skin crawling sensation; feeling of water droplets on skin; paresthesia began in bilateral feet (right worse than left).; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 29Jul2021 (Lot number: EN0158) at the age of 26 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: IBUPROFEN; MULTIVITAMIN [VITAMINS NOS]. The following information was reported: PARAESTHESIA (non-serious) with onset 04Aug2021, outcome "recovering", described as "tingling"; PARAESTHESIA (non-serious) with onset 04Aug2021, outcome "recovering", described as "Paresthesia"; FATIGUE (non-serious) with onset 04Aug2021, outcome "recovering", described as "fatigue"; DIZZINESS (non-serious) with onset 04Aug2021, outcome "recovering", described as "lightheadedness"; ASTHENIA (non-serious) with onset 04Aug2021, outcome "recovering", described as "weakness"; PRURITUS (non-serious) with onset 04Aug2021, outcome "recovering", described as "itching"; PAIN (non-serious) with onset 04Aug2021, outcome "recovering", described as "shooting pains"; FORMICATION (non-serious) with onset 04Aug2021, outcome "recovering", described as "skin crawling sensation"; PARAESTHESIA (non-serious) with onset 04Aug2021, outcome "recovering", described as "feeling of water droplets on skin"; CONDITION AGGRAVATED (non-serious) with onset 04Aug2021, outcome "recovering", described as "paresthesia began in bilateral feet (right worse than left).". The events "tingling", "paresthesia", "fatigue", "lightheadedness", "weakness", "itching", "shooting pains", "skin crawling sensation", "feeling of water droplets on skin" and "paresthesia began in bilateral feet (right worse than left)." were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of paraesthesia, paraesthesia, fatigue, dizziness, asthenia, pruritus, pain, formication, paraesthesia, condition aggravated.  Additional Information: Paresthesia increased in frequency and intensity over the next several weeks. Feelings included tingling, pins/needles, itching, shooting pains, skin crawling sensation, feeling of water droplets on skin. Paresthesia spread to fingers, face, scalp and lower legs. PCP ran bloodwork including vitamin b12, vitamin d, TSH/T4, A1c; all resulted normal. Paresthesia began to subside after about 7 weeks, so  received my second dose on 20Sep2021. Two weeks after second dose, I began having widespread fasciculation's that lasted about 2 weeks. The paresthesia did not get worse after the second dose. Fatigue, lightheadedness and weakness did not return after second dose. Overall symptoms are about 80% better at almost 14 weeks post first vaccine dose.  No follow-up attempts are possible. No further information is expected.  Follow-up attempts are completed. No further information is expected.